|Legal and Administrative<br>Details|Legal and Administrative<br>Details|Legal and Administrative<br>Details|||1-2|
|---|---|---|---|---|---|
|Chairman's|Annual<br>Report||||3-4|
|Trustees'<br>Report,<br>including||the Strategic report|||5 - 18|
|Independent|Auditor's<br>Report||||19 - 22|
|Consolidated|Statement<br>of|Financial|Activities||23|
|Comparative|Consolidated|Statement|of Financial|Activities|24|
|Consolidated|Balance Sheet||||25|
|Charity Balance Sheet|||||26|
|Consolidated|Statement<br>of|Cash Flows|||27|
|Principal<br>accounting<br>policies|||||28 - 31|
|Notes to the|financial statements||||32 - 51|



## 



## 

|<br>the Truste|<br>the Truste|<br>es.|y<br>|trougout<br>this report are collectively<br>referre|d to|
|---|---|---|---|---|---|
|Company||registration|number:|01231909||
|Charity|registration||number:|270194||
|Registered||Office:||Milton<br>Road||
|||||Willen Village||
|||||Milton Keynes||
|||||MK15 9AB||
|Trustees:||||P Davis (Chairman) '<br>~<br>I Philpott ''' "(Resigned 28'"july 2022)<br>M Stevenson '' 4<br>R Gilbert '4 '||
|||||P Ball (Appointed 1"April 2021)<br>C Dunn ' (Resigned 28'" October 2021)<br>M Rogers'' '<br>SCarbe*'' '||
|||||jWood"<br>A Coombes ' (Resigned 30'"April 2022)<br>C White-Robinson '<br>M Esam '||
|||||S Moore (Appointed<br>28'" October 2021)<br>D Kulczykowska '<br>(Appointed<br>24'" February|2022)|
|||||Member of Business Development||
|||||Committee/WHV<br>Ltd Board||
|||||Member of General<br>Purposes 5 Finance||
|||||Committee<br>(Including<br>IMMIT)||
|||||Member of People Services Committee||
|||||Member of Property<br>Committee||
|||||Member of Clinical Governance<br>Committee<br>Member of Health 5Safety Committee||
|||||Integrated<br>Governance<br>Committee||





## 

## 



## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 



## 

## 



## 

## 



## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

|Total|Free|reserves:|14,485,991|14,485,991|
|---|---|---|---|---|
|Less|fixed|asset designated|reserves:||
|||Property<br>Hospice Development<br>Other fixed assets||(1,803,403)<br>(1,289,768)<br>~337821|
|||||f11054 999|



## 

## 



## 

## 

## 

## 

## 

## 



## 

## 



## 



## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

|||||||Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|---|---|---|---|---|
|||||||Funds|Funds|2022|2021|
||||||Note|||||
|Income||||||||||
|Donations<br>and voluntary|||income|||||||
|Voluntary<br>income|||||1|5,190,037|400,153|5,590,190|4,045,525|
|Grant funding|||||||1,604,187|1,604,187|1,636,834|
|Income from generated||funds||||||||
|Income from Clinical||Commissioning||Group||1,306,620||1,306,620|1,294,877|
|Activities<br>for raising|funds|||||1,183,630||1,183,630|1,156,552|
|Investment<br>income||||||225,891||225,891|225,649|
|Other income||||||224,634||224,634|1,569,378|
|Total income||||||8 130812|2004340|10135152|9928015|
|Expenditure||||||||||
|Cost of raising funds<br>Charitable<br>activities<br>Impairment<br>of investments|||||7<br>7<br>13|(2,516,738)<br>(4,110,628)|(1,744,164)|(2,516,738)<br>(5,854,792)|(2,223,916)<br>(5,069,412)<br>188438|
|Total expenditure||||||||||
|Gain / (Loss) on investment|||assets||13|148690||148690|1 058 692|
|Net income / (expenditure)<br>Transfers||||||1,652,136<br>1 743|260,176<br>~1743|1,912,312|3,892,617|
|Net movements<br>in funds||||||1,653,879|2583433|19127312|3892617|
|Fund balances brought|forward at|||||||||
|1 April 2021<br>Fund balances carried <br>March 2022|forward at 31||||21/23|14213298<br>15867 177|650 596<br>909029|14 863 894<br>16776 206|10971 277<br>14063094|





## 

||||||Unrestricted|Restricted|Total|
|---|---|---|---|---|---|---|---|
||||||Funds|Funds|2021|
||||||E|||
|Income||||||||
|Donations<br>and voluntary|||income|||||
|Voluntary<br>income|||||3,118,933|926,592|4,045,525|
|Grant funding||||||1,636,834|1,636,834|
|Income from generated||funds||||||
|Income from Clinical||Commissioning||Group|1,294,877||1,294,877|
|Activities for raising||funds|||1,156,552||1,156,552|
|Investment<br>income|||||225,649||226,649|
|Other income|||||1,569,378||1,569,378|
|Total income|||||7,365,389|2,563,426|9,928,815|
|Expenditure||||||||
|Cost of raising<br>funds<br>Charitable<br>activities|||||(2,223,916)<br>(3,109,546)|(1,959,866)|(2,223,916)<br>(5,069,412)|
|Impairment<br>of investment|||||198438||198438|
|Total expenditure|||||(5,135,024)|(1 9597866)|(77094890)|
|(Loss) / Gain on investment|||assets||1 058 692||1058 692|
|Net income / (expenditure)|||||3,289,057|603,560|3,892,617|
|Transfers||||||||
|Net movements<br>in funds|||||3,289,057|603,560|3,892,617|
|Fund balances<br>brought|forward at 1 April|||||||
|2020<br>Fund balances carried <br>2021||forward at 31||l6iarch|10924 241<br>14213298|47 036<br>656 596|10971277<br>14863894|





## 

|||||2022|2022|2021|2021|
|---|---|---|---|---|---|---|---|
||||Note|f.||E|E|
|Fixed assets||||||||
|Intangible<br>assets|||||25,851||32,687|
|Tangible assets|||12||4,436,411||2,583,414|
|Investments|||13||8 515677||8 190880|
||||||12,977,939||10,806,981|
|Current assets||||||||
|Stocks|||14|33,864||35,531||
|Debtors|||15|3,215,355||2,013,665||
|Cash and cash equivalents|||16|2 371 109||2 574 684||
|Creditors: amounts||falling due within||5,620,328||4,623,880||
|one year|||17|(1,715,061)||566 967||
|Net current assets|||||3,905,267||4,056,913|
|Provisions<br>for liabilities|||18||(107,000)|||
|Net assets|||||16,776,206||14,863,894|
|Income Funds||||||||
|Restricted<br>funds|||21||909,029||650,596|
|Unrestricted<br>funds||||||||
|Designated<br>funds|||22||3,494,521||5,784,320|
|Other charitable|funds||23||10,991,470||7,196,482|
|Revaluation<br>reserve|||23||1 381 186||1 232 496|
|Totalfunds|||||16,776,206||14,863,894|





## 

||||Note|2022f|2022f|2021<br>E|2021<br>f|
|---|---|---|---|---|---|---|---|
|Fixed assets||||||||
|Intangible<br>assets<br>Tangible assets<br>Investment<br>in subsidiary<br>Investments||undertaking|12<br>13<br>13||25,851<br>4,436,411<br>2<br>8 515677||32,687<br>2,583,414<br>2<br>8 190880|
|Current assets|||||12,977,941||10,806,983|
|Debtors<br>Cash and cash equivalents|||15<br>16|3,560,972<br>1 779 743||2,368,260<br>1 854 049||
|Creditors: amounts|falling due within|||5,290,753||4,222,309||
|one year|||17|~1477 785||311584||
|Net current assets|||||3,862,930||3,910,725|
|Provisions<br>for liabilities|||18||(107,000)|||
|Net assets|||||16733 871||14717708|
|Income Funds||||||||
|Restricted<br>funds<br>Unrestricted<br>funds:|||21||909,029||650,596|
|Designated<br>funds<br>Other charitable<br>funds<br>Revaluation<br>reserve<br>Total funds|||22<br>23<br>23||3,494,521<br>10,949,135<br>1 381 186<br>16733871||5,784,320<br>7,050,296<br>1 232 496<br>14 717708|





|||2022|2022|2021|2021|
|---|---|---|---|---|---|
|Cash flows from operating<br>activities|Notes|||||
|Net income / (expenditure)||1,912,312||3,892,617||
|Adjustments<br>for:||||||
|Investment<br>income<br>Amortisation<br>Depreciation<br>Profit on disposal of investment<br>(Increase)/decrease<br>in stocks<br>(Increase)/decrease<br>in trade and<br>other receivables|11<br>12<br>13<br>14<br>15|(225,891)<br>10,046<br>289,956<br>(4,317)<br>1,667<br>(1,201,690)||(225,649)<br>7,792<br>189,740<br>22,082<br>(854,649)||
|(Decrease)/increase<br>in trade and other<br>paya bles|17|1,148,094||61,575||
|Movement<br>on pension<br>scheme<br>Increase/<br>(decrease)<br>in provisions<br>Revaluation<br>of investments<br>Impairment<br>of investments|17<br>18<br>13<br>13|107,000<br>(148,690)||(1,059,667)<br>(198,438)||
|Cash flows generated<br>from<br>operating<br>activities|||1,888,487||1,835,403|
|Purchase of property<br>plant and<br>equipment|12|(2,142,953)||(267,237)||
|Purchase of intangible<br>fixed assets<br>Purchase of investments<br>Proceeds from sale of investments<br>Investment<br>income|11<br>13<br>13|(3,210)<br>(178,656)<br>6,866<br>225 891||(18,691)<br>(145,147)<br>6,086<br>225 649||
|Cash flows generated<br>from investing<br>activities|||(2I092I062)||(199,340)|
|Net (decrease) / increase<br>in cash<br>and cash equivalents|||(203,575)||1,636,063|
|Cash and cash equivalents<br>at 1 April|||2,574,684||938,621|
|Cash and cash equivalents<br>at 31 March|16||2371 109||2 574684|





## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

|DGAa'tloAs<br>and|volUAta|l g lAcorAe||||
|---|---|---|---|---|---|
|||Unrestricted<br>f|Restricted<br>f|Total<br>2022<br>f|Total<br>2021|
|Donations<br>(including<br>Gifts in kind<br>Legacies<br>Memorials<br>Donated goods<br>Friends of Willen|gift aid)|1,336,833<br>31,169<br>1,443,473<br>255,260<br>2,095,359|400,153|1,736,986<br>31,169<br>1,443,473<br>255,260<br>2,095,359|2,112,754<br>47,447<br>962,435<br>244,692<br>650,678|
|Christmas<br>Appeal<br>Grant funding||27,943|1,604,187|27,943<br>1,604,187|27,519<br>1,636,834|
|||5 190037|2 004 340|7 194377|5 682 359|



## 

||||2022|2021|
|---|---|---|---|---|
|Unrestricted<br>funds|||||
|Lottery income|||||
|Events and promotions<br>income<br>Profit from Willen Hospice Ventures||shops|468,676<br>565,203<br>149751|466,231<br>610,659<br>79 662|
||||1,183,630|1,156,552|



## 

|||2022|2021|
|---|---|---|---|
|Unrestricted|funds|||
|Listed investments||||
|Bank deposits||225,082<br>809|224,981<br>668|
|||225,891|225,649|





## 

## 

|||||2021|2021|
|---|---|---|---|---|---|
|Unrestricted|funds|||||
|Education||||41,583|35,799|
|Catering||||29,032|16,442|
|3ob Retention|Scheme|||823|229,326|
|CCG COVID-19 Funding|||||875,373|
|8usiness<br>Interruption|||Scheme Claim||194,069|
|Retail business|support||grant|100,275|191,835|
|Other miscellaneous||income||11,830|9,867|
|Profit on sale of investment||||4,317||
|Shop Rent||||36 774|16667|
|||||224,634|1,569,378|



|||||||2022|2021|
|---|---|---|---|---|---|---|---|
|Turnover||||||2,717,388|1,635,271|
|Cost of sales||||||263 948|169834|
|Gross profit||||||2,453,440|1,465,437|
|Administrative|expenses|||||(2,115,469)|(1,767,596)|
|Other operating|income|||||101,098|556,851|
|Operating<br>profit||||||439,069|254,692|
|Interest receivable||and similar income||||102|184|
|Profit for the year||and total comprehensive||income||439,171|254,876|
|The net assets||and liabilities ofthe subsidiary|||were:|||
|||||||2022|2021|
|Current assets||||||660,709|1,068,621|
|Creditors:<br>amounts||falling due within|one|year||(618,369)|(922,433)|
|Total net assets||||||42,340|146,188|
|Aggregate<br>share capital and reserves||||||42,340|146,188|





## 

|||||Support|||
|---|---|---|---|---|---|---|
||||Direct costs|costs|Total|Total|
|||||(Note below)|2022|2021|
|||||f|||
|Cost of raising funds|||||||
|Trading|||1,252,248|91,244|1,343,492|1,295,696|
|Lottery|||216,398|40,374|256,772|211,220|
|Events and fundraising|||373,325|228,648|601,973|416,361|
|Voluntary|fundraising|costs|314501||314501|300 639|
||||2,156,472|360,266|2,516,738|2,223,916|
|Charitable|activities||||||
|In house|||2,768,428|580,651|3,349,079|2,845,198|
|Willen At Home|||1,100,877|153,679|1,254,556|1,119,956|
|Wellbeing|&Therapeutic||689,677|120,402|810,079|772,233|
|Lymphoedema<br>Service|||222,901|45,785|268,686|231,223|
|Governance|||21 106|151286|172392|100802|
||||4,802,989|1,051,803|5,854,792|5,069,412|
|Other expenses|||||||
|Impairment|of investments|||||~198438|
|Total expenditure|||6,959,461|1,412,069|8,371,530|790947890|



## 



## 

|||||The group|The charity||
|---|---|---|---|---|---|---|
||||2022|2021|2022|2021|
||||||f|f|
|Auditor<br>remuneration|||||||
|Audit services|||15,100|12,150|||
|Non-audit|services||2,450|1,350|||
|Amortisation|||10,046|7,792|10,046|7,792|
|Depreciation|||289,956|189,740|289,956|189,740|
|Other operating||lease rentals|342,621|(6,728)|342,621|(6,728)|



## 

|mployees|mployees||||
|---|---|---|---|---|
|Staff costs during||the year were as follows:|||
||||2022|2021|
|Salaries and wages|||4,740,164|4,318,025|
|Social security costs|||413,548|379,961|
|Pension costs|||395,234|391,514|
||||5,548,946|5,089,500|
|Contract staff|||379,487|367,029|
|Health<br>Examination|fees||6,559|329|
||||5,934,992|5,456,858|





## 

## 



## 

|||ITsofhvare|Total|
|---|---|---|---|
|Cost||||
|At 1 April 2021||115,705|115,705|
|Additions||3,210|3,210|
|Disposals||||
|At 31March|2022|118,915|118,915|
|Amortisation||||
|At 1 April 2021||83,018|83,018|
|Arnortisation|in the year|10,046|10,046|
|On disposals||||
|At 31March|2022|93,064|93,064|
|Net book amount at 31March 2022||25,851|25,851|
|Net book amount at 31March 2021||32,687|32,687|





|||Asset under|||
|---|---|---|---|---|
||Freehold<br>propertyf|course of<br>constructionf|Equipmentf|Fundraising<br>assetsf|
|Cost|||||
|At 1 April 2021|3,053,004|309,026|646,219|378,396|
|Additions||2,086,589|38,492|4,615|
|Disposals|||||
|At 31March 2022|3,053,004|2,395,615|684,711|383,011|
|Depreciation|||||
|At 1 April 2021|1,189,931||526,162|306,335|
|Depreciation<br>in the year|59,676||32,828|18,943|
|Disposals|||||
|At 31March 2022|1,249,607||558,990|325,278|
|Net book amount at|||||
|31 March 2022|1,803,397|2,395,615|125,721|57,733|
|Net book amount at|||||
|31March 2021|1,863,073|309,026|120,057|72,061|





## 

## 

|||IT|Motor|Leasehold|||
|---|---|---|---|---|---|---|
|||hardware<br>f|vehicles|improvements||Total|
|Cost|||||||
|At 1 April 2021||281,300|42,774|158,027||4,868,746|
|Additions||10,785||2,472||2,142,953|
|Disposals|||||||
|At 31March|2022|292,085|42,774|160,499||7,011,699|
|Depreciation|||||||
|At 1 April 2021||189,958|36,490|36,456||2,285,332|
|Depreciation|in the year|53,165|1,301|124,043||289,956|
|Disposals|||||||
|At 31March|2022|243,123|37,791|160,499||2,575,288|
|Net book amount at 31|||||||
|March 2022||48,962|4,983|||4,436,411|
|Net book amount at 31|||||||
|March 2021||91,342|6,284|121,571|2,583,414||





|||Historical<br>cost|Impairment|Revaluation|Market<br>valuef|
|---|---|---|---|---|---|
|Valuation||||||
|At 1 April 2021||6,958,384||1,232,496|8,190,880|
|Purchases<br>and additions<br>reinvestment|from|178,656|||178,656|
|Disposals||(2,549)||(4,317)|(6,866)|
|(Impairment)<br>/ reversal|of|||||
|impairment||||||
|Realised<br>Gain||||||
|Unrealised<br>gain on revaluation||||153,007|153,007|
|At 31March 2022||7,134,491||1,381,186|8,515,677|



## 

## 




## 

## 

|||The group<br>2022|2021|The charity<br>2022|2021|
|---|---|---|---|---|---|
|Trade debtors<br>Other debtors<br>Prepayments|and accrued|344,920<br>147,719|50,711<br>128,316|336,795<br>147,360|48,156<br>116,178|
|income<br>Amounts<br>owed by subsidiary||2,722,716|1,834,638|2,695,723|1,536,876|
|undertaking||||381094|667 050|
|||3,215,355|2,013,665|3,560,968|2,368,260|



## 

|||The group<br>2022|The group<br>2022|2021<br>f|The charity<br>2022|2021|
|---|---|---|---|---|---|---|
|Cash at bank and<br>in hand||2,371,090||2,538,046|1,779,724|1,817,411|
|Cash held at investment|manager|19||36,638|19|36,638|
|||2,371,109||2,574,684|1,779,743|1,854,049|
|Creditors: amounts|falling|due within|one|year|||
|||2022|The group<br>2021||The charity<br>2022|2021|
|Trade creditors<br>Social security and other taxes<br>Pension contributions<br>Other creditors<br>Accruals and deferred<br>income||813,796<br>95,938<br>60,742<br>8,544<br>736 041||87,321<br>91,913<br>59,542<br>1,245<br>326 946|738,266<br>95,938<br>60,742<br>8,544<br>574 295|75,096<br>78,094<br>53,654<br>1,062<br>103678|
|||1,715,061||566,967|1477 785|311584|



## 



## 

## 

||||2022|The group<br>2021|The charity<br>2022<br>2021|The charity<br>2022<br>2021|
|---|---|---|---|---|---|---|
|Dilapidation<br>provisions|||107000||107000||
||||107,000||107000||
|Financial instruments|||||||
||||The <br>2022|group<br>2021|The charity<br>2022|2021|
|Financial assets:|||||||
|Financial|assets measured|at fair|||||
|value through<br>profit and loss|||2,421,071|2,574,684|1,965,705|1,854,049|
|Financial|assets measured|at|||||
|amortised|cost||2,995,098|1,811,040|3,117,425|2,249,265|
|Financial|liabilities:||5,416,169|4,385,724|4,947,130|4,103,314|
|Financial|liabilities<br>measured|at|||||
|amortised|cost||1,490,042|336,994|1,487,621|224,418|



## 



## 

## 

||||Unrestricted|Restricted||
|---|---|---|---|---|---|
||||fundsf|funds|Total funds|
|Intangible|fixed assets|||||
|Tangible<br>fixed assets|||25,851||25,851|
|Investments|||4,436,411||4,436,411|
|Current assets|||8,515,677||8,515,677|
|Current<br>liabilities|||4,661,337|958,991|5 620 328|
|Provisions|||(1,715,061)||(1,715,061)|
||||(107,000)||(107,000)|
||||15,817,215|909,029|16,776,206|
|Group —comparative||pear||||
||||Unrestricted|Restricted||
||||funds|fundsf|Totalfunds<br>f|
|Intangible<br>fixed assets<br>Tangible<br>fixed assets|||32,687||32,687|
|Investments|||2,583,414||2,583,414|
|Current assets|||8,190,880||8,190,880|
|Current<br>liabilities|||3,973,284|650,596|4,623,880|
||||(566,967)||(566,967)|
||||14,213,298|650,596|14,863,894|





## 

## 

## 

|The group and|the charity<br>|—current year||||
|---|---|---|---|---|---|
||At 1April<br>2021f|Income|Expenditure|Transfers|At<br>31March<br>2022|
|Education|2,282|66,000|||68,282|
|Clinical equipment|6,764|543|(1,493)|(106)|5,708|
|Willen at Home|257|2,162|(2,163)||257|
|Capital Appeal|309,845|462,127|(85,267)||686,705|
|Wellbeing<br>and Therapeutic|23,218|57,138|(42,823)|(5)|37,528|
|Miscellaneous|29,588|11,423|(9,650)|(1,633)|29,728|
|CCG COVID-19 Funding|278,642||(247,821)||30,821|
|Hospice<br>UK Funding||1,116,187|(1,116,187)|||
|Cancer Care in the||||||
|Community||164,635|(114,635)||50,000|
|Winter Pressures||112,000|(112,000)|||
|Bereavement<br>Project||12,125|(12,125)|||
|Total|650596|2~004g340|(Ii744'164)|(1,743)|909,026|



## 

## 



## 

## 

||At 1April<br>2020|Income<br>E|Expenditure<br>f|Transfers<br>f|At<br>31March<br>2021<br>E|
|---|---|---|---|---|---|
|Education<br>Clinical equipment<br>Willen at Home<br>Capital Appeal|3,287<br>5,364<br>7,790|13,566<br>33,043<br>302,055|(1,005)<br>(12,166)<br>(32,786)||2,282<br>6,764<br>257|
|Wellbeing<br>and Therapeutic<br>Miscellaneous<br>CCG COVID-19 Funding<br>Hospice<br>UK Funding<br>Cancer Care in the|3,382<br>27,213|66,160<br>47,565<br>286,988<br>1,636,834|(46,324)<br>(45,189)<br>(8,347)<br>(1,636,834)||309,845<br>23,218<br>29,588<br>278,641|
|Community||140,841|(140,841)|||
|Bereavement<br>Project<br>Total|47036|36,375<br>2I563427|(36,375)<br>(1I959867)||650,596|





||At 1April<br>2021|Expenditure|Transfers<br>(see<br>below)f|At 31March<br>2022f|
|---|---|---|---|---|
|Property<br>Hospice development<br>Other fixed assets<br>Retail outlet refurbishment|1,863,079<br>3,378,232<br>444,009<br>5,000|(59,676)<br>(2,088,464)<br>(106,188)||1,803,403<br>1,289,768<br>337,821|
|ITreplacement|25,000|||5,000|
|Clinicai equipment<br>Planned<br>preventative|36,000|(35,471)||25,000<br>529|
|maintenance|33,000||||
|Total|5,784,320|(2,289,7997||33,000<br>3,494,521|





|||At 1April<br>2020|Expenditure|Transfers<br>(see<br>below)f|At 31March<br>2021f|
|---|---|---|---|---|---|
|Property<br>Hospice deveiopment<br>Other fixed assets<br>The Well||1,982,975<br>3,788,061<br>261,779<br>83,000|(60,223)<br>(20,502)<br>(137,309)<br>(83,000)|(59,673)<br>(389,328)<br>319,539|1,863,079<br>3,378,232<br>444,009|
|Retail outlet refurbishment<br>IT replacement<br>Clinical equipment||18,000<br>59,000|(7,040)<br>(59,000)|(5,960)<br>25,000|5,000<br>25,000|
|Planned<br>preventative||||36,000|36,000|
|maintenance<br>Total||30,800<br>6,223,616|(367,073)|2,200<br>(72,222)|33,000<br>5,784,320|
|23 Unrestricted|funds|||||



||Designated<br>funds (see<br>note 21)|Other<br>charitable<br>funds|Revaluation<br>reserve|Total|
|---|---|---|---|---|
|At 1 April 2021<br>Income|5,784,320|7,196,482|1,232,496|14,213,298|
|Expenditure<br>Gain / (loss) on revaluation|(2,289,799)|8,130,812<br>(4,337,567)||8,130,812<br>(6,627,306)|
|Disposals|||153,007|153,007|
|Transfers (see note 13 &21)<br>At 31March 2022|3,494,521|1 743<br>10,991,470|(4,317)<br>1,381,186|(4,317)<br>1 743<br>15,867,177|





## 

||Designated<br>funds (see<br>note 22)|Other<br>charitable<br>funds|Revaluation<br>reserve|Total|
|---|---|---|---|---|
|At 1 April 2020<br>Income|6,223,615|4,526,822|173,804|10,924,241|
|Expenditure<br>Gain / (loss) on revaluation|(367,073)|7,365,389<br>(4,767,951)||7,365,389<br>(5,135,024)|
|Transfers (see note 22)<br>At 31March 2021|72 222<br>5,784,320|72 222<br>7,196,482|1,058,692<br>1,232,496|1,058,692<br>14,213,298|



||Designated<br>funds (see<br>note 22)<br>E|Other<br>charitable<br>funds|Revaluation<br>reserve|Totalf|
|---|---|---|---|---|
|At 1 April 2021<br>Income|5,784,320|7,050,297|1,232,496|14,067,113|
|Expenditure<br>Gain / (loss) on revaiuation|(2,289,799)|7,034,635<br>(3,137,540)||7,034,635<br>(5,427,339)|
|Disposals|||153,007|153,007|
|Transfers (see note 22)<br>At 31March 2022|3,494,521|1 743<br>10,949,135|(4,317)<br>1,381,186|(4,317)<br>1 743<br>15,824,842|



||Designated<br>funds (see<br>note 22)|Other<br>charitable<br>funds|Revaluation<br>reservef|Totalf|
|---|---|---|---|---|
|At 1 April 2020<br>Income|6,223,615|4,296,253|173,804|10,693,672|
|Expenditure<br>Gain / (loss) on revaluation|(367,073)|5,886,757<br>(3,204,936)||5,886,757<br>(3,572,009)|
|Transfers (see note 22)<br>At 31March 2021|72 222<br>5,784,320|72 222<br>7,050,296|1,058,692<br>1,232,496|(307,260)<br>14,067,112|





## 



## 



## 

## 

||2022<br>Land and|2021<br>Land and|2022|2021|
|---|---|---|---|---|
||buildingsf|buildingsf|Otherf|Otherf|
|In one year or less<br>Between two and five<br>years|1,418,298<br>367,986|3,314,456<br>864,287|14,061|26,196<br>10,657|
|Over five years|121250|150822|||
||1,907,534|4,329,565|14,061|36,853|



## 

## 

## 

